SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Axsome Therapeutics, Inc.
@AXSM_InsiderForm 4 Filing: TABUTEAU HERRIOT Sells $12.2M of $AXSM
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
Axsome Therapeutics, Inc.
Ticker: $AXSM
Transaction Value
$12.2M
Price/Share: $122.60
transaction date
2026-07-01
Shares: 99,332
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, TABUTEAU HERRIOT, holds the title of Chief Executive Officer at Axsome Therapeutics, Inc..
On 2026-07-01, the insider transacted 99,332 shares.The shares were transacted at a weighted average price of $122.60 per share, resulting in a total market-relevant value of $12.2M.
Executive Summary Summary
TABUTEAU HERRIOT (Chief Executive Officer) sold $12.2M of $AXSM
Post-Transaction Position: 7,229 shares
SEC Accession No: 0001193125-26-292985 (CIK: 1219927)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.